Smart Money Is Betting Big In MRNA Options
From Nasdaq: 2024-05-15 14:32:06
Whales have shown bullish interest in Moderna stock, with 41% of trades being bullish and 41% bearish. Options history reveals 8 puts worth $635,317 and 9 calls worth $600,368. Market movers are eyeing a price band of $100.0 to $175.0. Moderna had its initial public offering in December 2018 and has multiple mRNA development candidates in clinical trials. Current stock price is $128.34 with an anticipated earnings release in 78 days.
Read more at Nasdaq: Smart Money Is Betting Big In MRNA Options